|
Spire Healthcare Group PLC on Friday said it is reviewing options for the business, including a possible sale. The London-based private healthcare provider said it is working with lead financial adviser Rothschild & Co. ‘This process is highly preliminary and no decision has been made regarding whether any such option will be pursued at this stage,’ Spire added. The process has a ‘range of potential options’, and these include a possible sale of the company. The firm said it believes that its freehold property and ‘a well invested asset base’, among others, are not yet reflected by the market in full. Therefore, it actively gauges appropriate action that could drive long-term shareholder value. Spire said: ‘There can be no certainty either that any offer will be made for the company nor as to the terms of any offer, if made. The company is not in receipt of any approaches and is not in discussions with any parties in respect of a potential sale of the company at the time of this announcement.’ Spire shares rose 9.0% to 236.04 pence each on Friday morning in London, giving it a market capitalisation of £946.5 million. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
